WS helps Genentech with FDA approval of new drug
WASHINGTON, DC: Weber Shandwick aided Genentech on communications work leading to approval from the Food and Drug Administration (FDA) of Avastin, a drug used in treating metastatic breast cancer, sources told PRWeek.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.